Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Solid Tumors
Interventions: DRUG: INCB057643|DRUG: Gemcitabine|DRUG: Paclitaxel|DRUG: Rucaparib|DRUG: Abiraterone|DRUG: Ruxolitinib|DRUG: Azacitidine
Sponsor: Incyte Corporation